Our engagements
Curacell
Ongoing engagement
Curacell develops cell based immunotherapies for cancer treatment focusing on TILs (Tumor Infiltrating Lymphocytes), an investigational therapy aimed at a durable cure for solid tumor cancers.
More about CuracellStromaBio
Ongoing engagement
StromaBio AB is a clinical stage biopharma company developing Mesenchymal Stromal Cell (MSC) based cell therapies. Founded on more than two decades of world leading research, our aim is to bring new advanced therapies to patients with Acute Respiratory Distress Syndrome (ARDS), and neurodegenerative Alzheimer’s Disease (AD).
More about StromaBioCellcolabs
Spin-off/exit
Cellcolabs specialises in industrial GMP production of high-quality Mesenchymal Stem Cells (MSC) in order to make them available at scale. Our ultimate goal is to accelerate stem cell research and make stem cells available and affordable.
More about Cellcolabs